Live feed
Filing
SC 13D/A
SC 13D/A0001213900-24-023384·CLS Therapeutics, LLC
Schedule 13D ownership disclosure
XENETIC BIOSCIENCES INC
Security class unavailable · CUSIP: 984015503
Event date: 2024-03-18
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 85,000
- Percent of class
- 5.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-24-023384
- Form type
- SC 13D/A
- Filer
- CLS Therapeutics, LLC
- CIK
- CIK 1951493
- Filed
- Mar 18, 2024
- Reporting period
- Mar 18, 2024
- Description
- Schedule 13D beneficial ownership